Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 91.6 CHF -0.09%
Market Cap: 180.9B CHF

Intrinsic Value

The intrinsic value of one NOVN stock under the Base Case scenario is 94.4 CHF. Compared to the current market price of 91.6 CHF, Novartis AG is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NOVN Intrinsic Value
94.4 CHF
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novartis AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
NOVN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NOVN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Novartis AG
SIX:NOVN
CH
Pharmaceuticals
Market Cap
179.5B CHF
IPO
May 7, 2001
CH
Pharmaceuticals
Market Cap
179.5B CHF
IPO
May 7, 2001
Price
CHffalse
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Novartis AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novartis AG

Current Assets 25.1B
Cash & Short-Term Investments 7.1B
Receivables 8.7B
Other Current Assets 9.2B
Non-Current Assets 74.8B
Long-Term Investments 2.1B
PP&E 11.1B
Intangibles 52.4B
Other Non-Current Assets 9.2B
Efficiency

Free Cash Flow Analysis
Novartis AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Novartis AG

Revenue
53.3B USD
Cost of Revenue
-12.9B USD
Gross Profit
40.3B USD
Operating Expenses
-22.9B USD
Operating Income
17.4B USD
Other Expenses
-4.6B USD
Net Income
12.9B USD
Fundamental Scores

NOVN Profitability Score
Profitability Due Diligence

Novartis AG's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Net Income
68/100
Profitability
Score

Novartis AG's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

NOVN Solvency Score
Solvency Due Diligence

Novartis AG's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
63/100
Solvency
Score

Novartis AG's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NOVN Price Targets Summary
Novartis AG

Wall Street analysts forecast NOVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVN is 104.41 CHF with a low forecast of 78.78 CHF and a high forecast of 124.95 CHF.

Lowest
Price Target
78.78 CHF
14% Downside
Average
Price Target
104.41 CHF
14% Upside
Highest
Price Target
124.95 CHF
36% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NOVN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NOVN Insider Trading
Buy and sell transactions by insiders

NOVN News

Other Videos
What is the Intrinsic Value of one NOVN stock?

The intrinsic value of one NOVN stock under the Base Case scenario is 94.4 CHF.

Is NOVN stock undervalued or overvalued?

Compared to the current market price of 91.6 CHF, Novartis AG is Undervalued by 3%.

Back to Top